Platelet production can further increase 5–10-fold via thrombopoietin (TPO)–myeloproliferative leukemia (Mpl) receptor axis signaling by exogenous TPO mimetic drugs or TPO receptor (TPO-R) agonists [3]. This evidence concerns the gene TPO and leukemia.